Publicité
Publicité

LPCN

LPCN logo

Lipocine Inc.

8.06
USD
Sponsorisé
+0.53
+7.04%
09 janv., 15:58 UTC -5
Fermé
exchange

Après-marché

8.03

-0.03
-0.37%

LPCN Rapports sur les bénéfices

Ratio de surprise positive

LPCN a dépassé 27 des 40 dernières estimations.

68%

Prochain rapport

Date du prochain rapport
11 mars 2026
Estimate for Q4 25 (Revenue/ EPS)
$118.32K
/
-$0.62
Variation implicite de Q3 25 (Revenue/ EPS)
+2.89%
/
+5.08%
Variation implicite de Q4 24 (Revenue/ EPS)
-96.61%
/
-133.33%

Lipocine Inc. earnings per share and revenue

On 06 nov. 2025, LPCN reported earnings of -0.59 USD per share (EPS) for Q3 25, missing the estimate of -0.55 USD, resulting in a -7.12% surprise. Revenue reached 115.00 mille, compared to an expected 242.76 mille, with a -52.63% difference. The market reacted with a +3.13% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analystes forecast an EPS of -0.62 USD, with revenue projected to reach 118.32 mille USD, implying an hausse of 5.08% EPS, and hausse of 2.89% in Revenue from the last quarter.
FAQ
For Q3 2025, Lipocine Inc. reported EPS of -$0.59, missing estimates by -7.12%, and revenue of $115.00K, -52.63% below expectations.
The stock price moved up 3.13%, changed from $2.56 before the earnings release to $2.64 the day after.
The next earning report is scheduled for 11 mars 2026.
Based on 4 analystes, Lipocine Inc. is expected to report EPS of -$0.62 and revenue of $118.32K for Q4 2025.
Chèque FXEmpire's Earnings Calendar for today's list of reporting companies.
Publicité